Frank A. Lederle, MD; Hanna E. Bloomfield, MD, MPH
Potential Conflicts of Interest: None disclosed. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-0403.
Requests for Single Reprints: Frank A. Lederle, MD, Veterans Affairs Medical Center (111-O), Minneapolis, MN 55417; e-mail, frank.lederle@va.gov.
Current Author Addresses: Drs. Lederle and Bloomfield: Veterans Affairs Medical Center (111-O), Minneapolis, MN 55417.
Author Contributions: Conception and design: F.A. Lederle.
Analysis and interpretation of the data: F.A. Lederle.
Drafting of the article: F.A. Lederle.
Critical revision for important intellectual content: F.A. Lederle, H.E. Bloomfield.
Final approval of the article: F.A. Lederle, H.E. Bloomfield.
Provision of study materials or patients: F.A. Lederle.
Statistical expertise: F.A. Lederle.
Administrative, technical, or logistic support: F.A. Lederle.
Collection and assembly of data: F.A. Lederle.
Lederle FA, Bloomfield HE. Drug Treatment of Asymptomatic Hypertriglyceridemia to Prevent Pancreatitis: Where Is the Evidence?. Ann Intern Med. 2012;157:662–664. doi: https://doi.org/10.7326/0003-4819-157-9-201211060-00011
Download citation file:
© 2019
Published: Ann Intern Med. 2012;157(9):662-664.
DOI: 10.7326/0003-4819-157-9-201211060-00011
Cardiology, Coronary Risk Factors, Dyslipidemia, Gastroenterology/Hepatology, Pancreatic Disease.
Results provided by: